Pharmaceutical Research and Manufacturers of America (PhRMA) is a Washington, D.C.-based trade group for innovative biopharmaceutical companies. It lobbies Congress on drug and health policy matters — including Medicare and Medicaid rules, federal budget and appropriations, trade and intellectual property protections, and national security issues like pharmaceutical supply chains. It has reported hiring DLA Piper and spending about $240,000 across recent filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
KARINA LYNCH
The latest disclosures for this client.
DLA PIPER LLP (US)
Q4DLA PIPER LLP (US)
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
DLA PIPER LLP (US)
MARGARET MARTIN
DLA PIPER LLP (US)
RACHEL PORTMAN
DLA PIPER LLP (US)
RICHARD BURR
DLA PIPER LLP (US)
VINCENT SARUBBI jr
DLA PIPER LLP (US)
MAREN MCBRIDE
DLA PIPER LLP (US)
DLA PIPER LLP (US)
Q2DLA PIPER LLP (US)
Q1DLA PIPER LLP (US)
RR